Literature DB >> 22888632

[Casein kinase 2, the versatile regulator of cell survival].

Iu L Volodina, A A Shtil'.   

Abstract

Casein kinase 2 (CK2), a highly conservative, multifunctional serine/threonine protein kinase, is critically important for the regulation of a plethora of processes in eukaryotes, such as cell proliferation, differentiation and death. CK2 is expressed in all tissues; in particular, its amount and activity are elevated in tumor cells. Unlike many regulatory proteins CK2 permanently adopts an active conformation. Of the utmost importance are the anti-apoptotic functions of CK2. This protein kinase is capable of regulating cell survival at multiple levels including DNA repair, NF-kappaB, Wnt, PI3K/Akt and JAK-STAT signaling cascades, chaperones, activation of anti-apoptotic proteins and down-regulation of pro-apoptotic counterparts, in particular, caspases. The versatility of CK2-mediated phosphorylation ensures the survival of tumor cells exposed to stimuli that differ in the origin and mechanisms of cytotoxicity. This manifold mode of CK2-dependent survival makes this enzyme an important target for antitumor therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22888632

Source DB:  PubMed          Journal:  Mol Biol (Mosk)        ISSN: 0026-8984


  3 in total

1.  Deciphering the Acute Cellular Phosphoproteome Response to Irradiation with X-rays, Protons and Carbon Ions.

Authors:  Martin Winter; Ivana Dokic; Julian Schlegel; Uwe Warnken; Jürgen Debus; Amir Abdollahi; Martina Schnölzer
Journal:  Mol Cell Proteomics       Date:  2017-03-16       Impact factor: 5.911

2.  [CK2α Regulates the Metastases and Migration of Lung Adenocarcinoma 
A549 Cell Line through PI3K/Akt/GSK-3β Signal Pathway].

Authors:  Aibing Wu; Mingchun Li; Zongjiong Mai; Shujun Li; Zhixiong Yang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2017-04-20

Review 3.  Benzotriazole: An overview on its versatile biological behavior.

Authors:  I Briguglio; S Piras; P Corona; E Gavini; M Nieddu; G Boatto; A Carta
Journal:  Eur J Med Chem       Date:  2014-09-30       Impact factor: 6.514

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.